Wednesday 30 September 2015

Medical Gases And Equipment Market Analysis, Size, Segment To 2020 by Grand View Research, Inc.



The global medical gases and equipment market size is expected to reach USD 10.52 billion in 2020, according to a new report by Grand View Research, Inc. The increasing level of patients requiring emergency care, surgical interventions and respiratory disorders are expected to boost the medical gases market over the forecast period.
Further key findings from the report suggest:
·         Old age heightens the need for healthcare by making individuals more susceptible to diseases especially pertaining to the respiratory system and triggers patient hospitalization rates. Statistics estimated by the WHO suggest that 55% - 60% of patients admitted in hospitals are administered with gases. 
·         The presence of favorable initiatives such as the U.S. Food and Drug Administration Safety and Innovation Act are expected to high rendering driver for growth of medical gases market. The act provides manufacturer with elimination of drug user fee, enhancement of profit margins, and power to fill intellectual property right for development of new product. 
·         The pure medical gases segment was the largest, representing a revenue share of over 60.0% in 2013. Extensive use of oxygen as the first line of treatment during emergencies such as heart attack and suffocation, for providing life support to artificially vented patients, and in events such as COPD, major trauma and severe hemorrhage is expected to witness huge demand for oxygen over the forecast. 
·         Medical gas mixtures are also gaining demand owing to their use in sterilization of heat and moisture sensitive instruments and disposable medical devices, during cancer radiation therapy, pain management procedures, and measurement of oxygen and carbon dioxide levels in blood stream. The mixtures are estimated to witness growth at rate of over 11.0%. 
·         Vacuum systems owing to their use in providing safe and sufficient flows at desired pressure levels to the medical gas outlets or vacuum inlet terminals held the largest share in 2013. Its market size is expected to reach over USD 1.6 billion by 2020. Masks are identified as the fastest growing equipment registering a CAGR of over 9.0% during the forecast period. 
·         The market for North America in 2013 was valued at USD 2.4 billion, owing to factors such as the presence of favorable government initiatives pertaining to new product development, sophisticated healthcare infrastructure and increasing patient awareness levels coupled with relatively higher healthcare expenditures in the region. 
·         On the other hand, the Asia Pacific medical gas industry is expected to witness rapid rise in demand and is expected to exceed a value of USD 2.2 billion by 2020. Presence of large population bases and high prevalence of pulmonary diseases and emergency conditions in countries such as India and China are some factors accounting for such rapid growth. 
·         Prominent players operating in this market includes Air Liquide, Praxair Inc, Air Gas Inc, Linde Gas, Air Products and Chemicals Inc. 
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global medical gases and equipment market on the basis of product and region:
Medical Gases and Equipment Product Outlook
            • Medical Gases
                    • Medical Pure Gases
                            • Medical Air
                            • Carbon Dioxide
                            • Oxygen
                            • Nitrogen
                            • Nitrous Oxide
                            • Helium
                    • Medical Gas Mixtures
                            • Carbon Dioxide – Oxygen Mixtures
                            • Oxygen-Nitrous Oxide Mixtures
                            • Ethylene Oxide
                            • Oxyfume 2000
                            • Helium Oxygen Mixtures
                            • Aerobic Mixtures
                            • Anaerobic Mixtures
                            • Blood Gas Mixtures
                            • Laser Gas Mixtures
                            • Lung Mixtures
            • Medical Gas Equipment
                    • Manifolds
                    • Outlets
                    • Hose Assemblies and Valves
                    • Alarm Systems
                    • Cylinders and Accessories
                    • Flowmeters
                    • Regulators
                    • Medical Air Compressors
                    • Vacuum Systems
                    • Masks
Medical Gases and Equipment Regional Outlook
            • North America
            • Europe
            • Asia Pacific
            • RoW
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          


Neurostimulation Devices Market Trends, Company Share To 2020: Grand View Research, Inc.



The global neurostimulation devices market is estimated to reach USD 8.79 billion by 2020, according to a new report published by Grand View Research, Inc. The growing demand for minimally invasive surgeries is expected to boost penetration levels over the forecast period. Key benefits associated with these surgeries include shorter hospital stays and faster patient recovery durations.
As per the WHO, the global prevalence of chronic diseases is 40 million patients of migraine and 50 million epileptic patients. The presence of high unmet medical needs in these disease segments will lead to rapid growth of the neurostimulation devices market. Growing demand of add on therapy for neuromodulation is expected to drive market growth by widening the usage base of neurostimulation products.
Further key findings from the report suggest:
·         The advent of technologically advanced internal substitutes plays an integral role in this market and manufacturers focus on developing new products to curb problems associated with previous versions. For instance, minimally invasive transdermal neuromodulation technology was developed by Neurowave Medical Technologies and MRI safety incorporated devices were introduced by Medtronic Inc.
·         The market for spinal cord stimulators is expected to reach USD 4.47 billion by 2020. It is majorly driven by the presence of high market penetration rates of commercialized products such as Restore, Precision Plus. The introduction of technological advancements such as MRI safety enabled products and product innovations enhancing effectiveness of the products in this segment are expected to fuel future market growth.
·         Deep brain stimulators are expected to grow at a CAGR over 17.0% from 2014 to 2020. The growth is primarily driven by the presence of extensive R&D activities pertaining to the development of novel devices such as Activa by Medtronic, Libra by St. Jude Medical are FDA and CE approved.
·         The North American neurostimulation devices market is expected to grow at a CAGR of 12.9% from 2014 to 2020, to reach USD 5.11 billion in 2020 owing to, factors such as the presence of high patient disposable incomes and patient awareness levels coupled with sophisticated healthcare infrastructure and high prevalence of target diseases such as epilepsy, Parkinson’s disease and incontinence.
·         On the other hand, the Asia Pacific neurostimulation devices industry is expected to grow at a CAGR over 17.0% from 2014 to 2020. Key drivers of this market include the growing economic developments in emerging markets such as India and China, increasing healthcare expenditures. Moreover, the presence of unmet medical needs and untapped opportunities coupled with increasing patient disposable income levels are expected to serve as high impact rendering drivers.
·         Some prominent players operating in this market include Medtronic Inc., St. Jude Medical, Cyberonics and Boston Scientific Corporation. They majorly participate in rigorous R&D exercises to develop new products enabled with advance technologies. 
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/medical-devices
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          


Tuesday 29 September 2015

Biotechnology Market Forecast Report To 2020: Grand View Research, Inc.



Global biotechnology market size is expected to reach USD 604.40 billion by 2020, according to a new report by Grand View Research, Inc. Increasing demand for biotechnology based diagnostics and therapeutics solutions such as recombinant technology, red biotechnology and DNA sequencing is expected to serve as a high impact rendering driver during the forecast period.
The presence of government funded institutions such as the NBTB (National Biotechnology Board) and DBT (Department of Biotechnology) are carrying out R&D and product development exercises pertaining to this field. Funding and scientific updates rendered by these institutions are likely to boost market growth over the forecast period.
Application of biotechnological processes such as genetic engineering and genetic modification (GM) in agricultural and food products to meet the demand of the booming population is expected to encourage R&D. Biotechnology plays an integral role in catering to the ever increasing agricultural demands.
Further key findings from the report suggest:
·         Tissue engineering and regeneration held approximately 33.0% of the overall market owing to, the wide applications of tissue engineering in cell organs which have lost their functionality. Moreover, increasing incidence rates of Parkinson’s and Alzheimer’s is another vital driver of this industry as tissue regeneration technology helps repair damaged cells.
·         DNA sequencing is expected to be fastest growing segment over the forecast period as a consequence of their wide applications in different verticals such as agriculture, biology, medical and geology. Declining costs will further improve accessibility over the forecast period.
·         The application of biotechnology in the field of biopharmaceuticals generated the largest revenue in 2014. The market for biopharmaceuticals was valued at over USD 180.0 billion in the year. Biopharmaceuticals are further sub segmented into advanced drugs, orphan drugs, monoclonal antibodies and recombinant proteins.
·         Bioservices market is expected to witness the fastest growth over forecast period owing to, the rising clinical research activities undertaken by various pharmaceutical and biotechnological organizations. In addition, the rising demand for cost cutting, implementation of stringent government regulations and increasing complexity of biotechnological processes are some key drivers of this segment.
·         North America accounted for the largest share of the overall industry in 2013 with revenue over USD 113 billion, as a result of increasing R&D initiatives undertaken in the fields of biopharmacy and agriculture. The use of biotechnology tools for energy generation will also boost penetration rates during the forecast period.
·         Asia Pacific is expected to gain lucrative revenue share over the forecast period and is expected to register an annual growth of 14.0%. Rising awareness levels and government initiatives to improve healthcare infrastructure are likely to drive regional market growth.
·         Biotechnology players are classified based on the nature of their clientele. Key biotechnology players include Invitrogen, Cubist Pharmaceutical, Regeneron, Novo Nordisk, Amgen, Teva Pharmaceutical Industries, Roche Diagnostics, and Alkermes
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/biotechnology
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          


Friday 25 September 2015

Healthcare 3D Printing Market Share, Analysis, Trends To 2020 by Grand View Research, Inc.



The Global Healthcare 3D Printing Market is expected to reach USD 1,129.8 million by 2020, growing at an estimated CAGR of 15.6% from 2014 to 2020, according to a new study by Grand View Research, Inc. Growing need to produce automated products and increasing number of cost curbing initiatives undertaken by medical device manufacturers are expected to drive market growth during the forecast period. In addition, this technology serves as an effective tool in rendering simulations and clarity to healthcare practitioners while performing or preparing for complicated medical procedures.
Implants dominated the overall market in 2013, accounting for over 60.0% of global revenue, primarily owing to high procedure volumes. Growing demand for this technology as a cost effective and accurate tool is expected to drive segment growth during the forecast period.
Further key findings from the study suggest:
  • Polymers dominated the raw materials market in terms of share at over 35% in 2013 owing to their high usage rates in printing bio-models. The market for ceramics is expected to grow at a lucrative CAGR of 15.6% during the forecast period as it is widely used to manufacture the tooth or the mandible (jaw bone). Both these raw materials have been included in the U.S. FDA’s list of approved materials to be used for manufacturing implants that will be in contact with the body for long duration of time.
  • Photo-polymerization dominated the overall technology market and was valued at over USD 140 million in 2013. This technology is used widely by research organizations and companies to manufacture efficient and accurate bio-models.
  • Laser beam melting is expected to be the fastest growing technology, at an estimated CAGR of over 16% from 2014 to 2020 on account of its growing demand in manufacturing orthopedic implants and hip stems
  • North America was the largest regional market in 2013, accounting for over 35% of global revenue owing to the presence of high patient awareness levels, increasing healthcare expenditure, sophisticated healthcare infrastructure and increasing investment in R&D facilities pertaining to the development of 3D technologies based products
  • Europe is expected to be the fastest growing regional market over the forecast period. Presence of a large number of R&D funding programs and increasing demand for customized medical devices in this region is expected to drive market growth over the next six years
  • Key participants of this market include Envision TEC, Stratasys Inc., Materialise NV, 3D Systems Software, Bio-Rad Laboratories, Organovo, SOLS, Simbionix, Metamason, RegenHU Ltd., Youbionic, Bio3D Technologies Pte Ltd, 3D Matters Pte Ltd., 3D Systems Corporation (3DS), Ekso Bionics, Roche Pharmaceuticals, Renishaw plc., Robohand, Delcam India, Worrell, mobileOCT, Archam, Rainbow Biosciences, ALD Vacuum Technologies, and 3T RPD Ltd.
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/medical-devices
For the purpose of this study, Grand View Research has segmented the healthcare 3D printing market on the basis of application, technology, raw material and region:
Healthcare 3D Printing Application Outlook
            • Surgical Guides
                    • Orthopedic Surgical Guides
                    • Crani-maxillofacial Surgical Guides
                    • Dental Surgical Guides
            • Implants
                    • Orthopedic Implants
                    • Crani-maxillofacial Implants
                    • Dental Implants
            • Surgical Instruments
            • Bioengineering
Healthcare 3D Printing Technology Outlook
            • Electron Beam Melting
            • Laser Beam Melting
            • Photopolymerization
                    • Stereolithography
                    • Digital light processing (DLP)
                    • Two-Photon Polymerization (TPP)
            • Droplet Deposition
                    • Inkjet Printing (IJP)
                    • Fused Deposition Modeling (FDM)
                    • Multiphase Jet Solidification (MJS)
Healthcare 3D Printing Raw Material Outlook
            • Metals Market
            • Biological Cells
            • Polymers
            • Ceramics
Healthcare 3D Printing Regional Outlook
            • North America
            • Europe
            • Asia Pacific
            • RoW
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research